ONVO - long term investment in bioprinting

15 0 1
The company is looking to achieve an ambitious goal in the development and testing of drugs and explore the possibility of "printing" organs. If the first part works (3d bioprinted liver tissue) and is economically feasible - it will be gamechanger in cutting down the costs for pharma             companies to bring drugs to market.

This may be the future - and ONVO             is the public company where one may acquire direct ownership in this space(tissue regeneration) that I'm aware of. Are there others? Would like some guidance on that.

On to the technicals - the shares have consistently been under selling pressure since the beginning of the year. They are reaching important relative lows if one looks at the weekly and monthly charts. Given that they have sold off for some time now and are near higher timeframe support - this may the stock in a favorable position for accumulation.

I am currently looking at the $3 - 3.4 price level as one entry point and acquiring more shares if price retraces to the $2.75 level. I will be looking to acquire long term call options ( as of now Jan 2017) and possibly selling puts.

I'm usually not of a fan sub-$5 issues, but there is sufficient liquidity (+1m avg             daily volume ) and the upside potential good for the risk taken. My initial sell point would be the the $5.50 level.
EN English
EN English (UK)
EN English (IN)
DE Deutsch
FR Français
ES Español
IT Italiano
PL Polski
TR Türkçe
RU Русский
PT Português
ID Bahasa Indonesia
MS Bahasa Melayu
TH ภาษาไทย
VI Tiếng Việt
JA 日本語
KO 한국어
ZH 简体中文
ZH 繁體中文
AR العربية
Home Stock Screener Forex Signal Finder Cryptocurrency Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing My Support Tickets Contact Support Ideas Published Followers Following Private Messages Chat Sign Out